Zhejiang Vie Science & Technology Co Ltd
Zhejiang VIE Science & Technology Co., Ltd. engages in the research and development, production, and sale of automotive chassis control systems in China and internationally. It offers passenger car and commercial vehicle chassis control systems, including chassis front and rear suspension systems, automotive electronic control systems, pneumatic brake systems, hydraulic brake systems, clutch cont… Read more
Zhejiang Vie Science & Technology Co Ltd (002590) - Total Liabilities
Latest total liabilities as of September 2025: CN¥2.91 Billion CNY
Based on the latest financial reports, Zhejiang Vie Science & Technology Co Ltd (002590) has total liabilities worth CN¥2.91 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Zhejiang Vie Science & Technology Co Ltd - Total Liabilities Trend (2008–2024)
This chart illustrates how Zhejiang Vie Science & Technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Zhejiang Vie Science & Technology Co Ltd Competitors by Total Liabilities
The table below lists competitors of Zhejiang Vie Science & Technology Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nilfisk Holding A/S
CO:NLFSK
|
Denmark | Dkr588.00 Million |
|
SK IE Technology Co Ltd
KO:361610
|
Korea | ₩1.78 Trillion |
|
Hefei Fengle Seed Co Ltd
SHE:000713
|
China | CN¥1.54 Billion |
|
Weihai Huadong Automation Co Ltd
SHE:002248
|
China | CN¥395.55 Million |
|
Shandong Oriental Ocean Sci-Tech Co Ltd
SHE:002086
|
China | CN¥324.17 Million |
|
Monro Muffler Brake Inc
NASDAQ:MNRO
|
USA | $965.03 Million |
|
Aquestive Therapeutics Inc
NASDAQ:AQST
|
USA | $194.09 Million |
|
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
SHG:688505
|
China | CN¥207.05 Million |
Liability Composition Analysis (2008–2024)
This chart breaks down Zhejiang Vie Science & Technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.97 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.48 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Zhejiang Vie Science & Technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Zhejiang Vie Science & Technology Co Ltd (2008–2024)
The table below shows the annual total liabilities of Zhejiang Vie Science & Technology Co Ltd from 2008 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥2.93 Billion | -1.28% |
| 2023-12-31 | CN¥2.97 Billion | +7.17% |
| 2022-12-31 | CN¥2.77 Billion | +45.07% |
| 2021-12-31 | CN¥1.91 Billion | +14.22% |
| 2020-12-31 | CN¥1.67 Billion | +3.87% |
| 2019-12-31 | CN¥1.61 Billion | -1.69% |
| 2018-12-31 | CN¥1.64 Billion | +2.21% |
| 2017-12-31 | CN¥1.60 Billion | +12.55% |
| 2016-12-31 | CN¥1.42 Billion | +14.84% |
| 2015-12-31 | CN¥1.24 Billion | +15.92% |
| 2014-12-31 | CN¥1.07 Billion | -5.03% |
| 2013-12-31 | CN¥1.13 Billion | +18.21% |
| 2012-12-31 | CN¥952.82 Million | -1.16% |
| 2011-12-31 | CN¥963.96 Million | +35.76% |
| 2010-12-31 | CN¥710.07 Million | +48.97% |
| 2009-12-31 | CN¥476.66 Million | +23.32% |
| 2008-12-31 | CN¥386.53 Million | -- |